drugset / Trial / NCT00100308

Unfractioned Heparin for Treatment of Sepsis

NCT00100308

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether low dose continuous infusion of unfractioned heparin (500 units/hour), in addition to the standard treatment, is efficacious as complementary therapy for sepsis patients.

Timeline

Start
2005-07
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Unfractioned Heparin Unknown 500 iu